ライフサイエンスコーパス: miscarriage

1 .1-5.7) and timing of spontaneous abortions (miscarriages).

2 ation was a modifiable risk factor for early miscarriage.

3 The point is illustrated here in the case of miscarriage.

4 cterize the relationship between smoking and miscarriage.

5 be warned that smoking increases the risk of miscarriage.

6 cessful because of retarded fetal growth and miscarriage.

7 e, resulting in 10 ongoing pregnancies and 1 miscarriage.

8 placental function in karyotypically normal miscarriage.

9 nce in reducing transfer of embryos prone to miscarriage.

10 numab for a refractory CD and which ended in miscarriage.

11 ation in the placenta and that this leads to miscarriage.

12 regnancy stages at risk of influenza-related miscarriage.

13 vitamins in early pregnancy and the risk of miscarriage.

14 A total of 524 women had a miscarriage.

15 r pregnancy-related complications, including miscarriage.

16 elation between chemokine levels and risk of miscarriage.

17 ic ovarian syndrome are at increased risk of miscarriage.

18 okines are associated with increased risk of miscarriage.

19 sufficient protection against APS-associated miscarriage.

20 aneuploid conceptuses result in spontaneous miscarriage.

21 s of her fetus, and, to a lesser extent, for miscarriage.

22 ion is only partially successful in averting miscarriage.

23 bath during early pregnancy and the risk of miscarriage.

24 f such supplements affects the occurrence of miscarriage.

25 ng early pregnancy influenced their risk for miscarriage.

26 or sperm motility and may reduce the risk of miscarriage.

27 pre-eclampsia, fetal growth restriction, and miscarriage.

28 olymorphism may be associated with recurrent miscarriage.

29 outcome in women with unexplained recurrent miscarriage.

30 There does appear to be an increased risk of miscarriage.

31 at least 1 fibroid, and 10.8% experienced a miscarriage.

32 nts are associated with an increased risk of miscarriage.

33 and vivax malaria both increase the risk of miscarriage.

34 y, or before conception, to decrease risk of miscarriage.

35 rombophilic women with unexplained recurrent miscarriage.

36 elevated ferritin conferred stronger risk of miscarriage.

37 with an OR of 0.62 (95% CI: 0.41, 0.93) for miscarriage.

38 pherol was associated with decreased risk of miscarriage.

39 d with an increased risk of second-trimester miscarriage.

40 vival among women with unexplained recurrent miscarriage.

41 ng vitamin D as a modifiable risk factor for miscarriage.

42 ons, they are not recommended for preventing miscarriage.

43 phisms, in vitro fertilization failures, and miscarriages.

44 morigenesis, neuropsychiatric conditions and miscarriages.

45 omal rearrangement, or a history of multiple miscarriages.

46 inflammation in the deciduas and leading to miscarriages.

47 The sister had 6 miscarriages.

48 aternal infections account for 15% of early miscarriages.

49 ant increase in the risk of second trimester miscarriages.

50 omen with a history of unexplained recurrent miscarriages.

51 nic hypertransaminasemia (29%) and recurrent miscarriages (12%).

52 lications incurred during gestation included miscarriage (13.3%), preeclampsia (4.4%), gestational hy

53 ancies (69% live births, 1% stillbirths, 13% miscarriages, 13% abortions, 5% unknown or in gestation)

54 omen with VIUP (256 pg/mL; 168-442 pg/mL) or miscarriage (192 pg/mL; 133-476 pg/mL).

55 Incidence of miscarriage (2% in the standard care group vs 2% in the

56 without preterm delivery (269 [26.4%]), and miscarriage (262 [25.7%]).

57 Sixteen patients had 30 miscarriages (27%) and one term stillbirth.

58 heparin was associated with a higher rate of miscarriage (28.6% versus 9.2%; P<0.001) and late fetal

59 dds ratio was higher for stillbirth than for miscarriage (3.6 [1.4-9.4] vs 1.27 [0.94-1.71]).

60 % CI 1.78-7.66]), pregnancy complications or miscarriages (3.54 [1.47-8.55]), unwanted pregnancy (2.9

61 hedema 11%), sensorineural hearing loss 76%, miscarriage 33%, and hypothyroidism 14%.

62 included 256 women (mean age 32 years, >/=3 miscarriages: 72%; mean gestational age 39 days of ameno

63 Six miscarriages (8%) occurred during the first trimester.

64 There were 11 miscarriages (9%), 4 premature deliveries (3%), and 1 ea

65 llow-up groups: P0 (0 pregnancies), P1 (>/=1 miscarriages/abortions), B1 (1 birth), and B2 (>/=2 birt

66 associated with a twofold increased risk of miscarriage (adjusted hazard ratio (aHR) = 2.0, 95% conf

67 There were significantly more miscarriages (adjusted odds ratio=1.94, 95% CI=1.08-3.48

68 Miscarriage affects 20% of pregnancies and maternal inf

69 a livebirth (AHR 13.0 [95% CI 11.63-16.86]), miscarriage (AHR 6.07 [95% CI 4.83-7.62]), or terminatio

70 malaria, maternal and neonatal anaemia, and miscarriage, all of which increase the overall importanc

71 Four women experienced miscarriage, all of whom had received antenatal systemic

72 dversely affect fertility or first trimester miscarriage, although it is associated with a significan

73 The rates of miscarriage among women who had and had not taken folic

74 We examined the risk for miscarriage among women who had confirmed pregnancies an

75 There were 537 observed miscarriages among 4,070 women, 23% of whom self-identif

76 Twenty-three percent had experienced a prior miscarriage and 52% prior births.

77 ur were education and previous experience of miscarriage and antenatal care.

78 -G promoter region have been associated with miscarriage and asthma, whereas expression levels have b

79 Maternal age-related miscarriage and birth defects are predominantly a conseq

80 dance result in aneuploidy, a major cause of miscarriage and birth defects in human beings.

81 treatment of cancer and prevention of human miscarriage and birth defects.

82 inst the bleeding challenges associated with miscarriage and childbirth.

83 humans, and is the leading genetic cause of miscarriage and congenital birth defects.

84 due to an association with increased risk of miscarriage and congenital defects.

85 leagues extend this correlation to recurrent miscarriage and fetal growth restriction, revealing the

86 e) that shares features with human recurrent miscarriage and fetal growth restriction, we identified

87 Spontaneous miscarriage and fetal malformation rates after recovery

88 ibody-independent mouse model of spontaneous miscarriage and IUGR, and that complement activation cau

89 (0.2%) had both a history of early recurrent miscarriage and LAC positivity.

90 We examined the association between miscarriage and levels of maternal urinary cortisol duri

91 imester malaria and artemisinin treatment on miscarriage and major congenital malformations.

92 Among women who were pregnant, miscarriage and perinatal mortality was 2.7 times higher

93 ciated with several complications, including miscarriage and premature delivery.

94 ae and G. vaginalis are associated with late miscarriage and prematurity in high-risk pregnancies.

95 ions seem to be associated with infertility, miscarriage and prematurity.

96 male exposures, particularly in relation to miscarriage and preterm delivery.

97 ester significantly reduces the rate of late miscarriage and spontaneous preterm birth in a general o

98 are associated with amplified risks of late miscarriage and spontaneous preterm delivery.

99 CI 0.08-1.02], p = 0.053), or in the risk of miscarriage and stillbirth combined (pregnancy loss) (aH

100 We examined whether miscarriage and stillbirth increase later risk of myocar

101 atios for each of the outcomes by history of miscarriage and stillbirth.

102 7 weeks), growth restriction, pre-eclampsia, miscarriage and/or stillbirth.

103 There were 8 first-trimester miscarriages and 1 ectopic pregnancy.

104 Errors in meiosis result in miscarriages and are the leading cause of birth defects;

105 romosomes in meiosis is essential to prevent miscarriages and birth defects.

106 luenza infection, the effect of influenza on miscarriages and births remains unclear.

107 regation errors, a leading cause of frequent miscarriages and congenital defects.

108 creased lead exposure to higher incidence of miscarriages and fetal death, even at blood lead elevati

109 There were 71 miscarriages and five terminated pregnancies.

110 ental dysfunction in patients with recurrent miscarriages and intrauterine growth restriction (IUGR),

111 be a good treatment for women with recurrent miscarriages and IUGR.

112 mber of chromosomes, is the leading cause of miscarriages and mental retardation in humans and is a h

113 mosome mis-segregation, the leading cause of miscarriages and mental retardation in humans.

114 ociated with an increased occurrence of both miscarriages and multiple births, which has resulted in

115 led to a 3-fold increase in pregnancy loss (miscarriages and perinatal mortality).

116 nt of severe pregnancy complications such as miscarriages and preterm delivery.

117 nd reduced risks of P(4)-resistant recurrent miscarriages and remission of endometriosis, these findi

118 Research into the preventability of miscarriages and stillbirths is hampered in the United S

119 bryonic growth, manifesting in preeclampsia, miscarriages and/or preterm birth.

120 known incidence of chromosomal aneuploidy in miscarriage, and it has been suggested that there is an

121 he leading genetic abnormality that leads to miscarriage, and it is caused by a failure of accurate c

122 pherol was associated with increased risk of miscarriage, and low gamma-tocopherol was associated wit

123 m birth, preeclampsia, gestational diabetes, miscarriage, and stillbirth).

124 ree unexposed cohorts: women with livebirth, miscarriage, and termination of their first pregnancies.

125 ace is independently associated with risk of miscarriage, and the higher risk for black women is conc

126 Thirty-one women had a miscarriage, and three fetuses had intrauterine death.

127 ages lead to elevated rates of infertility, miscarriage, and trisomic conceptions.

128 velopmental delays, congenital skin lesions, miscarriage, and/or stillbirth.

129 rst birth, number of still births, number of miscarriages, and lack of breastfeeding were positively

130 at are associated with recurrent thrombosis, miscarriages, and neurological symptoms.

131 ustment for maternal age, number of previous miscarriages, and whether or not the couple had had a pr

132 evels were associated with increased risk of miscarriage as the collection-outcome interval increased

133 The increased risk of miscarriage associated with high MF was consistently obs

134 There was no difference in the risk of miscarriage associated with the use of artemisinins anyt

135 ely impaired placental formation, leading to miscarriage at days 10-12 of pregnancy.

136 losses were not divided into stillbirths and miscarriages because gestational age was not reliably re

137 Miscarriage before 20 weeks of gestation was ascertained

138 ined recurrent miscarriage (>/=2 consecutive miscarriages before 15 weeks' gestation) and a negative

139 ia trachomatis (Ct) has been associated with miscarriage but the underlying mechanisms are unknown.

140 osure during pregnancy increased the risk of miscarriage by 11% (95% CI: 0.95, 1.31; n = 17 studies).

141 valuation of a historic construction-related miscarriage cluster in the USA Today Building (1987-1988

142 The miscarriage cohort consisted of women attending a medica

143 nd alcohol use, blacks had increased risk of miscarriage compared with whites (adjusted hazard ratio

144 of congenital malformations and spontaneous miscarriages compared with those of non-diabetic women.

145 Using a mouse model of recurrent spontaneous miscarriages (DBA/2-mated CBA/J mice) that shares featur

146 ing to conceive 1% of couples have recurrent miscarriages, defined as three or more consecutive pregn

147 rgical removal of fibroids to reduce risk of miscarriage deserves careful scrutiny.

148 oductive performance, including infertility, miscarriage, diabetes-related congenital malformations,

149 ombosis, collagen vascular disease, multiple miscarriages, diabetes, autoimmune disease, and Fabry's

150 number of pregnancies, full-term births, or miscarriages, differed little between women with and wit

151 We analysed the frequencies of miscarriage (fetal loss at or before 28 weeks of gestati

152 These serious consequences include miscarriage, fetal death or an infant born with birth de

153 In 8 of 11 miscarriages for which cytogenetic data were available,

154 c villi was assessed in chromosomally normal miscarriages from women with RM (N = 33) or isolated mis

155 omen with a history of unexplained recurrent miscarriage (>/=2 consecutive miscarriages before 15 wee

156 with women with no miscarriages, women with miscarriages had 1.13 (1.03-1.24), 1.16 (1.07-1.25), and

157 ng early pregnancy, and women with recurrent miscarriage have lower endometrial expression of FST dur

158 cause and treatment of women with recurrent miscarriage have not withstood scrutiny, but progress ha

159 higher MF levels had 2.72 times the risk of miscarriage (hazard ratio = 2.72, 95% CI: 1.42-5.19) tha

160 The majority of miscarriages, however, occur earlier, within the first 3

161 ons between specific food groups and risk of miscarriage; however, to our knowledge, no previous stud

162 ted with a >2-fold increased adjusted HR for miscarriage (HR: 2.50; 95% CI: 1.10, 5.69).

163 with fetal loss, with an increased risk for miscarriage in couples in which both partners carried th

164 No difference was noted in miscarriage in first-line falciparum treatments with art

165 Presence of fibroids was associated with miscarriage in models without adjustments.

166 ic infection can result in acute illness and miscarriage in pregnant women.

167 h has emphasised the importance of recurrent miscarriage in the range of reproductive failure linking

168 The corresponding odds ratios for miscarriage in these subgroups were 0.8 (0.2-3.6), 1.7 (

169 HLA-G isoform was associated with recurrent miscarriage in two independent studies, suggesting that

170 was conducted to identify studies reporting miscarriage in women with and without history of exposur

171 plementation trial was done to assess ORs of miscarriage in women with low alpha-tocopherol (<12.0 mu

172 overy at birth, symptomatic hypotension, and miscarriage in women.

173 h pandemic influenza causing first trimester miscarriages in approximately 1 in 10 pregnant women.

174 were attributable to excess first trimester miscarriages in approximately 1 in 10 women who were pre

175 t contribute to the high rate of spontaneous miscarriages in human pregnancies.

176 iovascular disease, and an increased risk of miscarriages in humans.

177 disruption may contribute to thrombosis and miscarriages in the antiphospholipid syndrome (APS).

178 men, 1 gave birth to a healthy infant, 2 had miscarriages in the first trimester, and 1 had fetal dea

179 We found an excess of miscarriages in the offspring of affected women (p=0.001

180 by recurrent arterial/venous thrombosis and miscarriages in the persistent presence of autoantibodie

181 een PER2 transcript levels and the number of miscarriages in women suffering reproductive failure (Sp

182 ications to women with unexplained recurrent miscarriage, in the presence or absence of inherited thr

183 ere analysed for first-trimester malaria and miscarriage, in which 2558 (10%) had first-trimester mal

184 ptions are aneuploid, leading to spontaneous miscarriages, in vitro fertilization failures and, when

185 The hazard of miscarriage increased 1.61-fold after an initial first-t

186 term hormone use lowered risk; and recurrent miscarriage increased risk.

187 The risk of miscarriage increased with the amount smoked (1% increas

188 ns were dose dependent, with each additional miscarriage increasing the rates of myocardial and cereb

189 analysis by gestational weeks (10 weeks) of miscarriage indicated positive associations of MEP, MEOH

190 ders (fetal growth restriction and recurrent miscarriage), indicating a role early in gestation for t

191 ve RM, more than three months after the last miscarriage, indicating that the memory CD8-T cell popul

192 regularity, age at first birth, stillbirths, miscarriages, infertility >/=1 year, infertility cause,

193 e pathophysiological processes that underlie miscarriage, intrauterine growth restriction, and pre-ec

194 Miscarriage is a common and poorly understood adverse pr

195 Miscarriage is a condition that affects 10%-15% of all c

196 We demonstrate that unexplained recurrent miscarriage is associated with significantly decreased e

197 Miscarriage is the most common negative outcome of pregn

198 omen with a history of unexplained recurrent miscarriages is uncertain.

199 Results suggest that a miscarriage late in reproductive life, followed by lack

200 irths (>/=22 wk), and 137 (35%) terminations/miscarriages (<22 wk).

201 ages from women with RM (N = 33) or isolated miscarriage (M; N = 21) and elective terminations (TA; N

202 Autosomal trisomy is a common cause of human miscarriage, malformations and learning disability.

203 Couples with unexplained recurrent miscarriage may have an alloimmune abnormality that prev

204 ative Perinatal Project cohort who had had a miscarriage (n=439) and controls (n=373) matched by gest

205 t-to-treat analyses that excluded women with miscarriages (n = 6), gestational diabetes (n = 32), or

206 ngs regularly care for patients experiencing miscarriage, neonatal death and stillbirth as part of th

207 Miscarriage occurred in three (0.2%) participants in the

208 Miscarriage occurs in 15% of clinical pregnancies.

209 gnancy was associated with decreased odds of miscarriage (odds ratio = 0.43, 95% confidence interval:

210 d eyes; skewed X-inactivation; and recurrent miscarriages of male fetuses.

211 on, use of another contraceptive, history of miscarriage or abortion for the first pregnancy, or havi

212 opment, and are a major cause of spontaneous miscarriage or birth defects.

213 hromosome segregation - essential to prevent miscarriage or developmental defects - thus occur throug

214 Pregnancies complicated by miscarriage or growth restriction were characterized by

215 it is unclear whether a pregnancy ending in miscarriage or induced abortion confers any protection.

216 ive births, and the possibility that data on miscarriage or induced abortion could have influenced th

217 nate, dihydroartemisinin, or artemether) and miscarriage or malformation was assessed using Cox regre

218 We noted no evidence of an increased risk of miscarriage or of major congenital malformations associa

219 lammatory mediators, which in turn may cause miscarriage or premature birth.

220 er PFOA nor PFOS showed any association with miscarriage or preterm birth.

221 our analysis was pregnancy loss (spontaneous miscarriage or stillbirth), and the secondary endpoints

222 pregnancies in the United States may end in miscarriage or stillbirth.

223 was not associated with an increased risk of miscarriage or stillbirth.

224 their outcome (live birth, perinatal death, miscarriage or termination) among women aged 15-45 years

225 in primigravidae or in women with a previous miscarriage or termination.

226 449 women with at least 2 consecutive early miscarriages or 1 late miscarriage were included during

227 o differences were found in the frequency of miscarriages or in the rate of congenital malformations.

228 eceiving clindamycin had significantly fewer miscarriages or preterm deliveries (13/244) than did tho

229 g in 24 states and caused 14 deaths and four miscarriages or stillbirths.

230 egnancies) had increased odds of spontaneous miscarriage (OR 1.54, 95% CI 1.02-2.32; I(2)=67%), antep

231 ) and was significantly related to recurrent miscarriage (OR=2.8, 95% CI: 1.1, 7.4).

232 l for gestational age, very low birthweight, miscarriage, or neonatal death, although few data were a

233 tational age, birthweight, pregnancy loss or miscarriage, or pre-eclampsia.

234 ing ectopic pregnancy (EP) versus livebirth, miscarriage, or termination in a first pregnancy.

235 in rates of second pregnancy, livebirth, EP, miscarriage, or terminations and complications of a seco

236 methylation may cause karyotypically normal miscarriage, particularly among women experiencing recur

237 h depression or anxiety have higher risks of miscarriage, perinatal death and decisions to terminate

238 with pregnancy complications, including late miscarriage, preeclampsia, and fetal growth restriction.

239 very (birth > or =24 but <37 weeks) and late miscarriage (pregnancy loss > or =13 but <24 weeks).

240 e association between self-reported race and miscarriage (pregnancy loss at <20 weeks) in a community

241 opherol were associated with reduced odds of miscarriage (pregnancy losses <24 wk of gestation) in wo

242 nificant differences in the overall rates of miscarriage, premature births, small full-term births, o

243 egnancy outcomes, including the frequency of miscarriage, premature births, small full-term infants,

244 ted four adverse fetal outcomes: stillbirth, miscarriage, preterm birth, and low birthweight.

245 of conception were evaluated in relation to miscarriage, preterm delivery, and small-for-gestational

246 or myelofibrosis and 5% had thrombosis; the miscarriage rate in thrombocythemic patients was 14%.

247 .33; 95% confidence interval, 1.03-1.70) and miscarriage (rate ratio, 1.31; 95% confidence interval,

248 ther AH significantly changes live birth and miscarriage rates needs further investigations.

249 In this study (the Recurrent Miscarriage [REMIS] Study), we investigated whether pate

250 Four of the 45 pregnancies (excluding miscarriages) required preterm hospitalization, resultin

251 Approximately 50% of first-trimester miscarriages result from fetal chromosome abnormalities.

252 correctly estimate the amniocentesis-related miscarriage risk (73.8% vs 59.0%; OR, 1.95 [95% CI, 1.39

253 e used proportional hazard models to examine miscarriage risk among black women compared with white w

254 the authors, or might represent an increased miscarriage risk only within the subset of the populatio

255 lly defined as during the pregnancy in which miscarriage risk was measured (summary relative risk rat

256 the association between high MF exposure and miscarriage risk.

257 between any of the evaluated chemokines and miscarriage risk.

258 for this chemokine as an early indicator of miscarriage risk.

259 een 25-45 years (n = 45) suffering recurrent miscarriage (RM), recurrent implantation failure (RIF) o

260 ticularly among women experiencing recurrent miscarriage (RM).

261 ent implantation failure (RIF) and recurrent miscarriages (RM).

262 Young age, multiple recent partners, prior miscarriage, smoking, menstrual cycle, and douching were

263 complications in pregnant women, leading to miscarriage, stillbirth, and birth defects.

264 observational studies comparing the risk of miscarriage, stillbirth, and major congenital anomaly (p

265 ational age, very small for gestational age, miscarriage, stillbirth, and neonatal death.

266 The corresponding risks of miscarriage, stillbirth, and pregnancy loss in a sensiti

267 Pregnancies were followed until miscarriage, stillbirth, maternal death, or live birth o

268 The rates of miscarriage, stillbirth, pregnancy loss, and congenital

269 d 2008, we identified a cohort of women with miscarriages, stillbirths, or live singleton births.

270 ociation between 25(OH)D and first-trimester miscarriages, suggesting vitamin D as a modifiable risk

271 moking was associated with increased risk of miscarriage (summary relative risk ratio = 1.23, 95% con

272 en reporting the combined adverse outcome of miscarriage, termination of pregnancy, stillbirth, or ne

273 at translocation defects could contribute to miscarriages that are caused by polyspermy.

274 h use during pregnancy increases the risk of miscarriage, the authors conducted a 1996-1998 populatio

275 Recurrent miscarriage, the loss of three or more consecutive pregn

276 For miscarriage, the OR was 3.51 (95% CI 1.15-10.77, I(2)=0.

277 ucation, obesity, and previous stillbirth or miscarriage, the risk estimate was essentially null (odd

278 usively shown to be causal in thrombosis and miscarriage, they are useful laboratory markers for the

279 Our data suggest that NMO-IgG can cause miscarriage, thus challenging the concept that NMO affec

280 Prior evidence attributing miscarriage to fibroids is potentially biased.

281 ere is little physiological evidence linking miscarriage to stress.

282 We randomly assigned women with recurrent miscarriages to receive twice-daily vaginal suppositorie

283 The overall rate of miscarriage was 9.1% (2155/23806).

284 Miscarriage was defined as loss before 20 weeks' gestati

285 Miscarriage was defined as the involuntary termination o

286 , the risk of early (<13 weeks of gestation) miscarriage was higher if the mother had been monitored

287 The adjusted hazard of first-trimester miscarriage was lower with higher 25(OH)D concentrations

288 Miscarriage was not associated with chemical activities

289 History of miscarriage was not associated with preeclampsia risk.

290 The risk of miscarriage was significantly higher in women with a his

291 The contribution of the terminal complex to miscarriage was supported by the finding that pregnancy

292 census of abortion providers; the number of miscarriages was estimated using data from the National

293 n induced abortions, although information on miscarriages was of lower quality.

294 t 2 consecutive early miscarriages or 1 late miscarriage were included during 5 to 8 weeks' gestation

295 iation between active or passive smoking and miscarriage were included in the meta-analysis.

296 pregnant women and newborns and one related miscarriage were reported.

297 estational age at pregnancy diagnosis and at miscarriage were similar for both groups of women.

298 ceptions are genetically abnormal and end in miscarriage, which is the commonest complication of preg

299 In comparison with women with an initial miscarriage, women who had an EP had a lower chance of a

300 Compared with women with no miscarriages, women with miscarriages had 1.13 (1.03-1.2